Exact Sciences Corp. Files 2024 10-K

Ticker: EXAS · Form: 10-K · Filed: 2025-02-19T00:00:00.000Z

Sentiment: neutral

Topics: 10-K, annual-report, healthcare, diagnostics

TL;DR

EXAS filed its 2024 10-K. Full financials out.

AI Summary

Exact Sciences Corp. filed its 2024 10-K on February 19, 2025, detailing its financial performance for the fiscal year ending December 31, 2024. The company, headquartered in Madison, WI, operates in the medical laboratories sector. This filing provides a comprehensive overview of its business, financial condition, and results of operations for the period.

Why It Matters

This 10-K filing provides investors and stakeholders with a detailed look at Exact Sciences Corp.'s financial health and operational performance for the 2024 fiscal year, crucial for understanding the company's trajectory and investment potential.

Risk Assessment

Risk Level: medium — 10-K filings are standard disclosures for public companies, but the inherent risks of the healthcare and diagnostics industry, coupled with Exact Sciences' specific business model, warrant a medium risk assessment.

Key Numbers

Key Players & Entities

FAQ

What were Exact Sciences Corp.'s total revenues for the fiscal year ended December 31, 2024?

The filing indicates the fiscal year end is December 31, 2024, and the report covers the period from January 1, 2024, to December 31, 2024. Specific revenue figures would be detailed within the financial statements of the 10-K.

What is the company's primary business segment?

Exact Sciences Corp. is classified under the SIC code 8071, which corresponds to SERVICES-MEDICAL LABORATORIES.

When was the company incorporated?

The state of incorporation for Exact Sciences Corp. is Delaware (DE).

What is the SEC file number for Exact Sciences Corp.?

The SEC file number for Exact Sciences Corp. is 001-35092.

Has the company's name changed previously?

Yes, the company was formerly known as EXACT CORP and its name change date was September 19, 2000.

From the Filing

0001124140-25-000020.txt : 20250219 0001124140-25-000020.hdr.sgml : 20250219 20250219171106 ACCESSION NUMBER: 0001124140-25-000020 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 144 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250219 DATE AS OF CHANGE: 20250219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EXACT SCIENCES CORP CENTRAL INDEX KEY: 0001124140 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204782291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35092 FILM NUMBER: 25641627 BUSINESS ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 BUSINESS PHONE: 608-284-5700 MAIL ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 FORMER COMPANY: FORMER CONFORMED NAME: EXACT CORP DATE OF NAME CHANGE: 20000919 10-K 1 exas-20241231.htm 10-K exas-20241231 0001124140 FALSE 2024 FY http://fasb.org/us-gaap/2024#BaseRateMember P3Y P3Y http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherOperatingIncomeExpenseNet http://fasb.org/srt/2024#ChiefExecutiveOfficerMember iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure exas:item exas:position exas:reportable_segment 0001124140 2024-01-01 2024-12-31 0001124140 2024-06-30 0001124140 2025-02-18 0001124140 2024-12-31 0001124140 2023-12-31 0001124140 2023-01-01 2023-12-31 0001124140 2022-01-01 2022-12-31 0001124140 us-gaap:CommonStockMember 2021-12-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001124140 us-gaap:RetainedEarningsMember 2021-12-31 0001124140 2021-12-31 0001124140 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001124140 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001124140 us-gaap:CommonStockMember 2022-12-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001124140 us-gaap:RetainedEarningsMember 2022-12-31 0001124140 2022-12-31 0001124140 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001124140 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001124140 us-gaap:CommonStockMember 2023-12-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001124140 us-gaap:RetainedEarningsMember 2023-12-31 0001124140 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0001124140 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-12-31 0001124140 us-gaap:CommonStockMember 2024-12-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001124140 us-gaap:RetainedEarningsMember 2024-12-31 0001124140 us-gaap:ConvertibleNotesPayableMember 2024-01-01 2024-12-31 0001124140 us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-12-31 0001124140 us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-12-31 0001124140 us-gaap:RestrictedStockMember 2024-01-01 2024-12-31 0001124140 us-gaap:RestrictedStockMember 2023-01-01 2023-12-31 0001124140 us-gaap:RestrictedStockMember 2022-01-01 2022-

View on Read The Filing